Details for New Drug Application (NDA): 208111
✉ Email this page to a colleague
The generic ingredient in AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE is azelastine hydrochloride; fluticasone propionate. There are twelve drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the azelastine hydrochloride; fluticasone propionate profile page.
Summary for 208111
Tradename: | AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE |
Applicant: | Padagis Israel |
Ingredient: | azelastine hydrochloride; fluticasone propionate |
Patents: | 0 |
Pharmacology for NDA: 208111
Mechanism of Action | Corticosteroid Hormone Receptor Agonists Histamine H1 Receptor Antagonists |
Suppliers and Packaging for NDA: 208111
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE | azelastine hydrochloride; fluticasone propionate | SPRAY, METERED;NASAL | 208111 | ANDA | Padagis Israel Pharmaceuticals Ltd | 45802-066 | 45802-066-01 | 1 BOTTLE in 1 CARTON (45802-066-01) / 120 SPRAY, METERED in 1 BOTTLE |
AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE | azelastine hydrochloride; fluticasone propionate | SPRAY, METERED;NASAL | 208111 | ANDA | Bryant Ranch Prepack | 63629-8612 | 63629-8612-1 | 1 BOTTLE in 1 CARTON (63629-8612-1) / 120 SPRAY, METERED in 1 BOTTLE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SPRAY, METERED;NASAL | Strength | 0.137MG/SPRAY;0.05MG/SPRAY | ||||
Approval Date: | Feb 18, 2021 | TE: | AB | RLD: | No |
Complete Access Available with Subscription